Disease: Proteins segment

CCCC

C4 Therapeutics, Inc. - Common Stock

-7.69% -7.69% 0

+ Medicine, Disease: Proteins Last highlighted: #CCCC SEC report: C4 Therapeutics, Inc. Statement of changes in beneficial ownership of securities SEC Filing Form 4 filed by C4 Therapeutics, Inc. -- SEC File Number

+ My List

We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.